CRC Research Update — September 14, 2026
Today's colorectal cancer research highlights
liver-mets
A collection of 60 issues
Pooled Analysis Examines Prognostic Value of KRAS Mutations and Liver Metastases
Skip to content
The CRC Digest
Pooled Analysis Examines Prognostic Value of KRAS Mutations and Liver Metastases
A pooled analysis of third-line placebo-controlled trials from the ARCAD CRC Database evaluated the prognostic impact of liver metastases and KRAS mutations in metastatic colorectal cancer patients. (Clinical Colorectal Cancer)
This content is
CRC Research Update — September 13, 2026
Today's colorectal cancer research highlights
CRC Research Update — September 12, 2026
Today's colorectal cancer research highlights
CRC Research Update — September 08, 2026
Today's colorectal cancer research highlights
CRC Research Update — September 05, 2026
Today's colorectal cancer research highlights
Circulating Tumor DNA Predicts Recurrence After Liver Metastasis Resection
Skip to content
The CRC Digest
◇ RESEARCH
Circulating Tumor DNA Predicts Recurrence After Liver Metastasis Resection
A systematic review and meta-analysis found that circulating tumor DNA (ctDNA) serves as a biomarker for recurrence after curative resection of colorectal cancer liver metastases, potentially guiding post-surgical surveillance strategies. (Clinical Colorectal Cancer)
This
CRC Research Update — September 02, 2026
Today's colorectal cancer research highlights
CRC Research Update — August 31, 2026
Today's colorectal cancer research highlights
Targeted m6A Demethylation of ZBTB7A Suppresses Liver Metastasis in Preclinical Models
Skip to content
The CRC Digest
Targeted m6A Demethylation of ZBTB7A Suppresses Liver Metastasis in Preclinical Models
Researchers identified ZBTB7A as an m6A-modified transcription factor that promotes colorectal cancer liver metastasis, with METTL3-mediated m6A modification of ZBTB7A facilitating recognition by the m6A reader YTHDF1/3 complex. (Molecular Cancer)
This content